Literature DB >> 20160194

Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians.

Matthew B Lanktree1, Sonia S Anand, Salim Yusuf, Robert A Hegele.   

Abstract

BACKGROUND: Functional copy number variation in the apolipoprotein(a) gene (LPA) underlies a variable number of protein kringle domains repeated in tandem in the lipoprotein(a) [Lp(a)] particle. Genomic analysis of LPA, including both single-nucleotide polymorphisms (SNPs) and kringle IV type 2 (KIV-2) copy number, has yet to be performed. METHODS AND
RESULTS: First, we genotyped 49 SNPs within 100 kb of LPA in a multiethnic sample comprising South Asians (n=330), Chinese (n=304), and European Caucasians (n=272). Second, using quantitative polymerase chain reaction, we estimated the KIV-2 copy number in each sample. European Caucasians had the lowest KIV-2 copy number but displayed the strongest correlation between KIV-2 copy number and plasma Lp(a) concentration (r(s)=-0.31, P=4.2 x 10(-7)). SNP rs10455872, only prevalent in European Caucasians, was strongly associated with both plasma Lp(a) concentration (P=4.2 x 10(-29)) and KIV-2 copy number (P=7.2 x 10(-5)). LPA SNP rs6415084, within the same haplotype block as the KIV-2 variation, was significantly associated with both Lp(a) concentration and KIV-2 copy number in the same direction in all 3 ethnicities [Lp(a), P=5.3 x 10(-7); KIV-2, P=2.6 x 10(-4)]. SNPs and KIV-2 copy number together explain a larger proportion of variation in plasma Lp(a) concentrations in European Caucasians (36%) than in Chinese (27%) or South Asians (21%).
CONCLUSIONS: LPA SNPs are in linkage disequilibrium with KIV-2 copy number, but KIV-2 copy number explains an increment in plasma Lp(a) variation over SNPs alone. Thus, both SNPs and KIV-2 copy number should be included in future genetic epidemiology studies of Lp(a).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20160194     DOI: 10.1161/CIRCGENETICS.109.907642

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  52 in total

Review 1.  Lp(a): Addressing a Target for Cardiovascular Disease Prevention.

Authors:  Nestor Vasquez; Parag H Joshi
Journal:  Curr Cardiol Rep       Date:  2019-07-31       Impact factor: 2.931

2.  Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population.

Authors:  Lin Ding; An Song; Meng Dai; Min Xu; Wanwan Sun; Baihui Xu; Jichao Sun; Tiange Wang; Yu Xu; Jieli Lu; Weiqing Wang; Yufang Bi; Guang Ning
Journal:  J Lipid Res       Date:  2015-02-03       Impact factor: 5.922

Review 3.  Lipoprotein(a): A Lipoprotein Whose Time Has Come.

Authors:  Erik Kelly; Linda Hemphill
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

Review 4.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

5.  Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk.

Authors:  James Ronald; Ramakrishnan Rajagopalan; Felecia Cerrato; Alex S Nord; Thomas Hatsukami; Ted Kohler; Santica Marcovina; Patrick Heagerty; Gail P Jarvik
Journal:  Stroke       Date:  2010-12-02       Impact factor: 7.914

Review 6.  Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Tina Tran; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2011-07-12       Impact factor: 1.894

7.  Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study.

Authors:  Jin Li; Leslie A Lange; Jeremy Sabourin; Qing Duan; William Valdar; Monte S Willis; Yun Li; James G Wilson; Ethan M Lange
Journal:  J Hum Genet       Date:  2015-09-17       Impact factor: 3.172

8.  Farnesoid X receptor represses hepatic human APOA gene expression.

Authors:  Indumathi Chennamsetty; Thierry Claudel; Karam M Kostner; Anna Baghdasaryan; Dagmar Kratky; Sanja Levak-Frank; Sasa Frank; Frank J Gonzalez; Michael Trauner; Gert M Kostner
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

9.  Nonsynonymous SNPs in LPA homologous to plasminogen deficiency mutants represent novel null apo(a) alleles.

Authors:  Benjamin M Morgan; Aimee N Brown; Nikita Deo; Tom W R Harrop; George Taiaroa; Peter D Mace; Sigurd M Wilbanks; Tony R Merriman; Michael J A Williams; Sally P A McCormick
Journal:  J Lipid Res       Date:  2019-12-05       Impact factor: 5.922

10.  Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults.

Authors:  Azadeh Beheshtian; Sanyog G Shitole; Alan Z Segal; Dana Leifer; Russell P Tracy; Daniel J Rader; Richard B Devereux; Jorge R Kizer
Journal:  Atherosclerosis       Date:  2016-08-20       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.